DirectRx
DirectRx is a private pharmaceutical repackager and physician dispensing company operating an FDA- and DEA-approved facility in Dawsonville, Georgia, serving urgent care centers, private practices, employer health clinics, worker's compensation providers, correctional facilities, and government facilities with pre-packaged medications, dispensing software, and managed billing services.
- Company typePrivate
- Founded-
- HeadquartersDawsonville, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What DirectRx does
DirectRx is a privately held pharmaceutical repackaging and physician dispensing company headquartered at 94 Worldwide Drive, Dawsonville, Georgia. The company operates a single FDA-approved facility (21 CFR Part 820) and is DEA-approved to repackage legend drugs, controlled substances across Schedules 2, 3, 3N, 4, and 5, and over-the-counter medications. Its core technology is an automated production line capable of manufacturing more than 2,000 bottles per hour, supported by a proprietary 20-step quality control process for purity, safety, and traceability, and a web-based ordering and dispensing software platform. The facility repackages over 2,000 generic, brand, and OTC medications in unit-of-use quantities for direct shipment to healthcare providers.
DirectRx sells turnkey in-office dispensing programs to urgent care centers, private practices across multiple specialties (orthopedic, anesthesiology, family medicine, podiatry, dermatology, pediatrics, oral surgery), employer health clinics, worker's compensation providers, cardiology practices, correctional facilities, and government facilities. Orders are placed through the company's web-based dispensing software and shipped directly to the practice. The company also provides managed insurance and worker's compensation billing services — handling claims, rejections, and appeals on behalf of providers — and offers a private labeling service for custom-branded medication labels.
Revenue is generated through three streams: direct sales of pre-packaged medications, managed services for insurance and worker's comp billing, and transaction-based fees on dispensed medications. Pricing is quote-based and not publicly disclosed. DirectRx maintains full compliance with the Drug Supply Chain Security Act (DQSA, enacted November 27, 2013) through a partnership with USMeds Pedigree Systems, which provides electronic drug pedigree document management. The company has 11-50 employees, no disclosed funding rounds, no disclosed revenue, and no public ownership structure; it appears to be independently operated as a focused niche player in the physician dispensing market.
DirectRx firmographics
Firmographics- Name
- DirectRx
- Legal name
- DirectRx
- Website
- https://directrx.net
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DirectRx is a private pharmaceutical repackager and physician dispensing company operating an FDA- and DEA-approved facility in Dawsonville, Georgia, serving urgent care centers, private practices, employer health clinics, worker's compensation providers, correctional facilities, and government facilities with pre-packaged medications, dispensing software, and managed billing services.
- Ownership category
- akta.pro rank
DirectRx industry classification
Industry- Product category
- Pharmaceutical Repackaging and Physician Dispensing
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Direct-to-Provider / Clinic Buy-and-Bill Distributors (HLAIAJAM)
- akta.pro secondary industries
- Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features) (IMALAIAJ), Controlled Substances & Compliance-Focused Pharmaceutical Distributors (HLAIAJAN)
Keywords
Where DirectRx is headquartered
LocationHeadquarters
- HQ city
- Dawsonville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
DirectRx business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Pre-packaged Medication Sales: Direct sale of FDA-approved pre-packaged generic and brand medications in unit-of-use quantities to healthcare providers. Medications are prepackaged, labeled, and distributed directly to practices for in-office dispensing.
- Insurance and Work Comp Billing Management: Billing management services for insurance and worker's compensation claims. DirectRx handles all medication billing, claims, rejections, and appeals on behalf of healthcare providers.
- Medication Dispensing Program: Provides point-of-care medication dispensing solutions enabling clinics to dispense medications directly at time of visit, creating additional revenue stream for practices.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
DirectRx product offering
Product offeringCore offering
DirectRx repackages and distributes FDA- and DEA-approved pre-packaged generic, brand, and OTC medications to licensed healthcare providers for point-of-care dispensing. It offers a turnkey medication dispensing program that includes online ordering/dispensing software, training, billing management for insurance and worker's compensation claims, and E-Pedigree/DQSA compliance documentation. Operations are run from a single DEA- and FDA-approved automated production facility in Dawsonville, GA.
Product overview
DirectRx offers a unified physician dispensing platform comprising pre-packaged medications and medication dispensing services. The core offering includes pharmaceutical repackaging of over 2,000 generic, brand, and OTC medications through an FDA and DEA-approved facility, processed via a 20-step quality control system. These pre-packaged medications feed directly into the Medication Dispensing Program, enabling clinics to dispense at point-of-care. The E-Pedigree service provides Drug Supply Chain Security Act compliance, while Private Labeling offers customization options. The company serves diverse healthcare settings including urgent care, private practices, employer health clinics, worker's compensation providers, cardiology practices, and correctional facilities.
Differentiator
Problem solved
Functional benefit
Products and services
- Pre-Packaged Medications
Quantifiable outcome
- 30% of prescriptions are never filled; in-office dispensing ensures prescriptions are filled at point of care
- +7 more outcomes
Companies that use DirectRx
Customer profileSegments7 records
Ideal customer profiles7 records
DirectRx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
DirectRx partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- USMeds Pedigree SystemscoreDirectRx has partnered with USMeds Pedigree Systems, a web-based pharmaceutical drug pedigree document management platform. This partnership enables DirectRx to maintain full compliance with the Drug Supply Security Act (DQSA) enacted into law on November 27, 2013. The platform provides e-pedigree tracking and document management for pharmaceutical drug traceability.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
DirectRx competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Cardinal Health is a top-3 U.S. drug distributor serving retail pharmacies, hospitals, and physician offices with pharmaceutical products and related services. It competes with DirectRx in serving physician dispensing programs, though its scale and product breadth are far larger.
- McKesson: McKesson is the largest U.S. pharmaceutical wholesaler, supplying retail pharmacies, hospitals, and direct-to-provider channels. It overlaps with DirectRx in distributing pre-packaged and unit-of-use pharmaceuticals to physician offices, but operates at vastly greater scale and breadth.
- Cencora (formerly AmerisourceBergen): Cencora is one of the largest global pharmaceutical solutions companies, distributing drugs and providing specialty physician-facing services. It overlaps with DirectRx in distributing pharmaceuticals and serving in-office dispensing customers, but at massive scale across the full healthcare supply chain.
Direct peers
- Anda Inc. Anda Inc. is a pharmaceutical distributor specializing in generic and brand drugs supplied to retail pharmacies, hospitals, and physician offices. It is a direct competitor in the pre-packaged/unit-dose distribution channel that DirectRx serves.
- RPharma (Repack): RPharma (a dba of Auburn Pharmaceutical) operates as a specialty pharmaceutical repackager and distributor serving physician offices. It competes head-to-head with DirectRx in pre-packaged unit-dose medications and physician dispensing programs.
- H.D. Smith: H.D. Smith is one of the largest independent pharmaceutical wholesalers in the U.S., distributing brand, generic, and specialty drugs to retail and institutional customers including physician offices. It overlaps with DirectRx's direct-to-provider distribution model.
- Morris & Dickson: Morris & Dickson is a U.S. pharmaceutical wholesaler focused on unit-dose and physician office distribution. It directly competes with DirectRx in supplying pre-packaged medications to physician offices, urgent cares, and specialty practices.
Regional players
- Smith Drug Company: Smith Drug Company is a regional pharmaceutical wholesaler serving independent pharmacies, hospitals, and physician offices primarily across the Southeast and Mid-Atlantic. It overlaps with DirectRx in unit-dose and physician-office distribution within similar geographies.
Others
- USMeds Pedigree Systems: USMeds Pedigree Systems is a web-based pharmaceutical drug pedigree document management platform with which DirectRx partners for DQSA compliance. It is an enabling technology partner rather than a competitor, but operates in the same regulatory ecosystem.
- MDScripts: MDScripts is the web-based physician dispensing software platform DirectRx uses for online ordering, inventory, and dispensing workflows. It is a core technology partner and an adjacent player in the physician dispensing ecosystem, sometimes competing for the same end customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
DirectRx social profiles
Digital presenceDirectRx compliance and trust
Trust signalCompliance4 records
DirectRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
DirectRx leadership team
Management profileNumber of profiles
Profiles1 record
DirectRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DirectRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DirectRx
What does DirectRx do?
DirectRx repackages and distributes FDA- and DEA-approved pre-packaged generic, brand, and OTC medications to licensed healthcare providers for point-of-care dispensing. It offers a turnkey medication dispensing program that includes online ordering/dispensing software, training, billing management for insurance and worker's compensation claims, and E-Pedigree/DQSA compliance documentation. Operations are run from a single DEA- and FDA-approved automated production facility in Dawsonville, GA.
Is DirectRx a public or private company?
DirectRx is a private company. It is classified as unknown and is currently operating.
When was DirectRx founded?
DirectRx was founded in -1. It employs 11 to 50 people.
Where is DirectRx based?
DirectRx is headquartered in Dawsonville, United States, in the North America region.
How does DirectRx make money?
Three revenue lines are on record. Pre-packaged Medication Sales are the primary driver. The others are insurance and Work Comp Billing Management and medication Dispensing Program.
Who are DirectRx's main competitors?
Broad incumbents on record are Cardinal Health, McKesson and Cencora (formerly AmerisourceBergen). Direct peers are Anda Inc., RPharma (Repack), H.D. Smith and Morris & Dickson. Smith Drug Company is listed as a regional player. Others are USMeds Pedigree Systems and MDScripts.
Does DirectRx have an API?
No public API is recorded for DirectRx.
What industry is DirectRx in?
DirectRx's product category is Pharmaceutical Repackaging and Physician Dispensing. Its primary akta.pro industry code is HLAIAJAM, Direct-to-Provider / Clinic Buy-and-Bill Distributors, with a secondary code of IMALAIAJ, Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features). Its NAICS code is 42421 and its SIC code is 5122.